A Single Centre, Two Treatment, Two Way, Single Oral Dose, Crossover Scintigraphy Study To Investigate The Two Rapid Release Solid Dosage Forms of Paracetamol Tablet In Eight Healthy Human (Male And Female) Subjects Under Fasting Condition.

Troikaa Pharmaceuticals Limited0 个研究点目标入组 8 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Human subjects aged between 18 and 55 years (including both). 2. Subjects weight within Â± 15% of the ideal height-weight chart of Life Insurance Corporation of India for non medical cases. 3. Ability to communicate effectively with study personnel. 4. Willingness to adhere to protocol requirement. 5.Be able to give consent for participation in the trial. 6. Normal healthy as determined by person medical history, clinical examination and laboratory examinations data during screening (within clinically acceptable range).

•1.History of hypersensitivity to any allergens known to them. 2.History or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, immunological, dermatological, neurological, psychiatric or any other body system involvement. 3.History of significant symptoms of cardiac dysfunction within one year. 4.Any history or presence of significant alcoholism or drug abuse within past one year. 5.History or presence of significant smoking (10 or more cigarettes per day) or consumption of tobacco product. 6.History or presence of significant asthma, urticaria or other allergic reactions following aspirin. 7.History or presence of significant gastric and/or duodenal ulceration. 8.History or presence of thyroid disease, adrenal dysfunction, organic intracranial lesion such as pituitary tumor. 9.History or presence of cancer. 10.Blood pressure less than 90/60 (Systolic/ diastolic) mm Hg or more than 140/95 mm Hg. 11.Pulse less than 45/minute or more than 110/minute. 12.Febrile. 13.Use of any prescribed medication during last two weeks or OTC medicinal products during the last one-week preceding the study. 14.Major illness during 3 months before the screening period. 15.Subjects who have been on abnormal diet for whatever reason during 4 weeks preceding the study. 16.Subjects who have participated in drug research study within past three months. 17.A positive pregnancy test in case of female volunteer of child bearing age.

发起方